ANGPTL4 expanded its footprint in diabetic complications this week — strong mechanistic data implicating it in proliferative diabetic retinopathy and a new review on its role in diabetic nephropathy — alongside cancer angiogenesis, lung-injury cytoprotection, and head-and-neck SCC prognosis. No new adipose-targeted RNA delivery papers (siRNA/ASO/LNP/GalNAc) appeared in the lookback window.